Modified Fluorinated Nucleoside Analogues

Patent No. EP2604620 (titled "Modified Fluorinated Nucleoside Analogues") was filed by Gilead Pharmasset on Apr 21, 2004. The application was issued on Oct 23, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GILLARD, RICHARD EDWARDMar 29, 2017ELKINGTON AND FIFE
AIDESMar 27, 2017JORGET
MÉDECINS DU MONDE ET ALMar 27, 2017JORGET
MEDICI SENZA FRONTIERE ONLUSMar 27, 2017JORGET

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2604620

GILEAD PHARMASSET
Application Number
EP13152340A
Filing Date
Apr 21, 2004
Status
Patent Maintained As Amended
May 17, 2024
Publication Date
Oct 23, 2024